Headache is one of the most commonly reported symptoms in the hEDS and HSD community, yet it is also one of the least systematically addressed in clinical practice. Most people with hEDS-related headaches will have seen multiple practitioners — general practitioners, neurologists, physiotherapists — without a clear explanation of why the headaches occur or how they relate to their connective tissue condition. The research is now providing clearer answers.
Prevalence: How Common Are Headaches in hEDS?
Studies included in the 2024 review report headache prevalence in hEDS cohorts ranging from 40–70%, compared to 12–15% in general population estimates for chronic or frequent headache. Migraine affects approximately 25–30% of people with hEDS, a rate substantially higher than the general population figure of around 12–15%. Daily persistent headache — headache occurring fifteen or more days per month — is also disproportionately represented.
Mechanisms: Why Does hEDS Cause Headaches?
The review identifies several overlapping mechanisms:
- Craniocervical instability (CCI): laxity in the ligaments supporting the craniocervical junction (occiput–C1–C2) may allow excessive movement that irritates the surrounding neural and vascular structures. The C1–C3 nerve roots, which share a nociceptive nucleus with the trigeminal nerve, are particularly relevant to headache generation.
- Intracranial pressure dysregulation: some people with hEDS have evidence of intracranial hypertension (raised CSF pressure) or CSF hypotension (leaks), both of which produce characteristic headache patterns. Postural headache (worse on standing, relieved by lying) should prompt consideration of CSF leak in this population.
- Central sensitisation: widespread nervous system sensitisation — common in hEDS and HSD — amplifies pain from all sources, including headache triggers that might be sub-threshold in someone without sensitisation.
- Dysautonomia: POTS and other autonomic dysfunction produce orthostatic headache through reduced cerebral perfusion on standing.
- Mast cell activation syndrome (MCAS): increasingly recognised as a comorbidity in hEDS, MCAS can contribute to headache through inflammatory mediator release.
A headache in someone with hEDS is not "just a headache." The underlying mechanism may be cervical, intracranial, autonomic, or sensitisation-driven — and each requires a different management approach.
Clinical Implications for Velca Practitioners
The review underscores that effective headache management in hEDS requires a multidisciplinary approach. At Velca Allied Health, this may involve:
- Cervical assessment and treatment for cervicogenic headache — with careful technique selection given craniocervical instability risk
- Autonomic assessment (MAPS screening, NASA Lean Test) for orthostatic headache
- Pain neuroscience education for central sensitisation-driven headache
- Referral for CSF pressure investigation where the headache pattern is positional
- Coordination with GP or neurologist for migraine management
This article is intended for general information purposes only and does not constitute medical advice. Please consult a qualified health professional for assessment, diagnosis, and treatment tailored to your individual circumstances. Velca Allied Health, 10 Wellington Street, Howick, Auckland 2014.